Responses
Oral Presentations
Osteoarthritis: new horizons for treatment
OP0168 A phase 2a, placebo-controlled, randomized study of ABT-981, an anti-interleukin-1ALPHA and -1BETA dual variable domain immunoglobulin, to treat erosive hand osteoarthritis (EHOA)
Compose a Response to This Article
Other responses
No responses have been published for this article.